Lv5
1440 积分 2024-05-21 加入
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
17小时前
求助中
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
17小时前
已完结
Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial
17小时前
已完结
Opportunities to improve the prevention and treatment of cervical cancer
18小时前
已完结
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
18小时前
已完结
Human Papillomavirus Infection and Cervical Cancer Prevention in Japan and Korea
18小时前
已完结
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
18小时前
已完结
Assessment of Clinically Relevant Immunogenicity for mAbs; are we Over Reporting ADA?
1个月前
已完结
Assessment of Clinically Relevant Immunogenicity for mAbs; are we Over Reporting ADA?
1个月前
已关闭
Pneumococcal conjugate vaccine schedule: 3+1, 2+1, or 1+1?
3个月前
已关闭
皖公网安备34019202002308
